Hyaluronic acid promotes Lgr5+ stem cell proliferation and crypt fission through TLR4 and PGE2 transactivation of EGFR

被引:26
|
作者
Riehl, Terrence E. [1 ]
Alvarado, David [1 ]
Ee, Xueping [1 ]
Ciorba, Matthew A. [1 ]
Stenson, William F. [1 ]
机构
[1] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2020年 / 319卷 / 01期
关键词
crypt fission; hyaluronic acid; Lgr5(+) stem cell; PGE2; TLR4; TOLL-LIKE RECEPTORS; EPIDERMAL-GROWTH-FACTOR; INTESTINAL STEM/PROGENITOR CELLS; IN-VITRO; INJURY; APOPTOSIS; PROSTAGLANDIN-E2; REGENERATION; RECOGNITION; ACTIVATION;
D O I
10.1152/ajpgi.00242.2019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We previously demonstrated that both CD44 and TLR4, but predominately TLR4, mediated HA stimulation of Lgr(5+) stem cell proliferation, crypt fission, and intestinal growth in postnatal mice. Here we address the questions of which cell type expresses the relevant TLR4 in driving intestinal growth and what are the downstream events from TLR4 activation. Studies were done in 14-day-old mice: wild type (WT), mice deficient in cyclooxygenase 2 (COX2), mice deficient in myeloid cell TLR4, and mice deficient in epithelial cell epidermal growth factor receptor (EGFR). Biological end points included crypt fission and Lgr5 cell proliferation. In WT mice, treatment with NS-398 (a COX2 inhibitor), clodronate (a macrophage-depleting agent), or tyrphostin (an EGFR inhibitor) resulted in 30% reductions in crypt fission and Lgr5(+) stem cell proliferation compared with control mice. Mice deficient in COX2 or myeloid TLR4 or epithelial cell EGFR all had 30% reductions in crypt fission and Lgr5(+) stem cell proliferation compared with WT mice. Administration of dimethyl PGE2, a stable PGE2 analog, increased crypt fission and Lgr5(+) stem cell proliferation. Administration of dimethyl PGE2 reversed the effects of NS-398, clodronate, COX2 deficiency, and myeloid TLR4 deficiency but had no effect on mice treated with tyrphostin or mice deficient in epithelial cell EGFR. We conclude that, in postnatal mice, similar to 30% of intestinal growth as manifested by crypt fission and Lgr5(+) stem cell proliferation is driven by a novel pathway: Extracellular HA binds TLR4 on pericryptal macrophages, inducing the production of PGE2 through COX2. PGE2 transactivates EGFR in Lgr5(+) epithelial stem cells, resulting in Lgr5(+) stem cell proliferation and crypt fission. NEW & NOTEWORTHY This study, in newborn mice, describes a novel molecular pathway regulating Lgr5(+) epithelial stem cell proliferation and normal intestinal elongation, as assessed by crypt fission. In this pathway, endogenous extracellular hyaluronic acid binds to Toll-like receptor 4 on pericryptal macrophages releasing PGE2 which binds to epidermal growth factor receptor on Lgr5(+) stem cells resulting in proliferation. Lgr5(+) stem cell proliferation leads to crypt fission and intestinal elongation. The demonstration that normal growth requires microbial-independent Toll-like receptor activation is novel.
引用
收藏
页码:G63 / G73
页数:11
相关论文
共 3 条
  • [1] CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice
    Riehl, Terrence E.
    Santhanam, Srikanth
    Foster, Lynne
    Ciorba, Matthew
    Stenson, William F.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2015, 309 (11): : G874 - G887
  • [2] Herbal melanin modulates PGE2 and IL-6 gastroprotective markers through COX-2 and TLR4 signaling in the gastric cancer cell line AGS
    El-Obeid, Adila
    Maashi, Yahya
    Alroshody, Rehab
    Alatar, Ghada
    Aljudayi, Modhi
    Al-Eidi, Hamad
    Algaith, Nouf
    Khan, Altaf Husain
    Hassib, Adil
    Matou-Nasri, Sabine
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [3] Original Article Lipopolysaccharide induces CCL2 through TLR4 signaling and promotes esophageal squamous cell carcinoma cell proliferation
    Sasamori, Ryohei
    Sato, Yusuke
    Nomura, Kyoko
    Wakita, Akiyuki
    Nagaki, Yushi
    Kemuriyama, Kohei
    Sasaki, Yoshihiro
    Nozaki, Shu
    Takahashi, Tsukasa
    Terata, Kaori
    Imai, Kazuhiro
    Minamiya, Yoshihiro
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07):